Seventh Sense Biosystems Secures $5,500,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3e9cb1b3-8b11-4604-8b8b-471e2b1312de - Date
11/17/2016 - Company Name
Seventh Sense Biosystems - Mailing Address
200 Boston Avenue Medford, MA 02155 USA - Company Description
The company’s proprietary TAP Touch Activated Phlebotomy technology enables painless, convenient and safe blood collection and is the foundation for a rich pipeline of products from painless, one-step sampling to integrated collection and analysis for a total decentralized testing solution - Website
http://www.7sbio.com - Transaction Type
Venture Equity - Transaction Amount
$5,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 7 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
